Skip to main content
. 2023 Sep 5;13:1200625. doi: 10.3389/fonc.2023.1200625

Table 5.

Relationship between the degree of tumour shrinkage assessed by imaging and the rate of pathological response after different cycles of treatment.

Characteristics Number of Neoadjuvant therapy cycles (%) P value
2 (n=150) 3-4 (n=101)
> 44.2% reduction in tumor length n=83 n=46 0.205
 MPR 66 (79.5) 32 (69.6)
 Non-MPR 17 (20.5) 14 (30.4)
≤44.2% reduction in tumor length n=67 n=55 0.048
 MPR 20 (29.9) 26 (47.3)
 Non-MPR 47 (70.1) 29 (52.7)

MPR, major pathological response.